St Jude Medical receives CE Mark approval for Infinity DBS system

St Jude Medical has announced that its Infinity deep brain stimulation (DBS) system and directional DBS lead have received European CE Mark approval.

The system will be available in two sizes and is the only upgradeable DBS system available to patients affected by movement disorders. It is suitable for people with Parkinson's disease, tremor and dystonia, a disorder characterised by involuntary muscle contractions.

Infinity uses Bluetooth wireless technology to communicate between the St Jude Medical Infinity DBS platform and Apple digital devices, allowing them to be used as patient and physician controllers.

Meanwhile, the newly-approved directional DBS lead allows physicians to shape the therapy to a patient's specific needs, while avoiding stimulation to areas that may create side effects.

Dr Eric Fain, group president at St Jude Medical, said this product launch "represents a major step forward in our DBS product portfolio, demonstrating St Jude Medical's commitment to patient-centric solutions to help alleviate the debilitating effects of movement disorders".

This comes after the company received CE Mark approval for its 27mm and 29mm Portico transcatheter aortic valve replacement system earlier this month.